HEIDI CANNAN: Open Payments
NPI 1598258121 · ROME, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 20 payments from 11 companies in 2025. Trend: 2023 $1,038 · 2024 $636 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $102 |
| Verona Pharma, Inc. | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Grifols USA, LLC | 2 | $34 |
| Amgen Inc. | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: VERQUVO, Ohtuvayre, Kerendia, OFEV, Prolastin-C Liquid, REPATHA, FARXIGA, FUROSCIX.
Industry payments across NY — which companies pay providers there.
